Escherichia coli

Escherichia coli is a Gram-negative, rod-shaped bacterium of the family Enterobacteriaceae and a normal inhabitant of the lower intestinal tract of humans and other warm-blooded animals. It is a facultative anaerobe that grows rapidly on simple defined media, and its small, fully sequenced genome and extensive genetic toolkit have made it the reference prokaryotic model organism for molecular biology. Most strains are harmless commensals, while defined lineages — including enterohemorrhagic E. coli O157:H7 and extraintestinal pathogenic strains — cause diarrheal illness, urinary tract infection, neonatal meningitis, and sepsis. Foodborne and wound-associated E. coli is a routine benchmark Gram-negative organism in antimicrobial testing, typically evaluated alongside Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans to distinguish activity across the Gram-negative outer membrane, the Gram-positive cell wall, and the fungal envelope.

The outer membrane of E. coli, with its lipopolysaccharide leaflet and selective porins, restricts entry of hydrophobic and large-molecule antimicrobials and underlies much of the organism's intrinsic resistance; acquired β-lactamases, including carbapenemases such as NDM-5, extend that resistance to front-line drugs. E. coli also forms biofilms in which an extracellular polymeric matrix reduces antibiotic penetration and metabolic activity, a phenotype targeted by plant-derived agents such as carvacrol and other essential-oil constituents, by polyphenols including rutin, kaempferol, curcumin, and resveratrol, and by metal and metal-oxide nanoparticles such as silver, zinc oxide, and selenium nanoparticles. Many of these agents act at least in part by generating reactive oxygen species and hydrogen peroxide that impose oxidative stress and compromise membrane integrity, effects often measured together with antioxidant and glutathione-related readouts. In parallel, E. coli remains a principal engineering chassis: serine-integrase and CRISPR-Cas systems, including CRISPR-Cas12a, permit precise, iterative genome modification, supporting recombinant protein expression in strains such as BL21(DE3) and metabolic-engineering routes to amino acid, nucleotides, glycosides, and related compounds, as well as its use in biosensor and synthetic-biology platforms.